Wanlan Huang - Allgens Medical Deputy Director
688613 Stock | 16.46 0.35 2.08% |
Director
Wanlan Huang is Deputy Director of Allgens Medical Technology
Age | 82 |
Address | No. 5 Kaikai Road, Beijing, China, 100026 |
Phone | 86 10 5633 0938 |
Web | https://www.allgensmed.cn |
Allgens Medical Management Efficiency
The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0128) %, meaning that it generated substantial loss on money invested by shareholders. Allgens Medical's management efficiency ratios could be used to measure how well Allgens Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of March 23, 2025, Total Assets is expected to decline to about 1.1 B. In addition to that, Non Current Assets Total is expected to decline to about 257.9 MSimilar Executives
Showing other executives | DIRECTOR Age | ||
Angelcapg Hu | Ningbo Daye Garden | 55 | |
Wen Xie | Qumei Furniture Group | 58 | |
Chao Sun | Ningbo Homelink Eco iTech | 46 | |
Reng Zhan | Nanxing Furniture Machinery | 56 | |
Bo Wang | Ningbo Homelink Eco iTech | 38 | |
Tao Wang | Nanjing OLO Home | 39 | |
Huiqin Lin | Ningbo Homelink Eco iTech | 59 | |
Qing Zhang | Masterwork Machinery | 52 | |
Rui Zhao | Qumei Furniture Group | 52 | |
Xiao Sun | Qumei Furniture Group | 35 | |
Qun Sui | Masterwork Machinery | 59 | |
Chong Li | Nanxing Furniture Machinery | 54 | |
Xiang Li | Ningbo Homelink Eco iTech | 48 | |
Liu Yaoguang | Hunan Tyen Machinery | 60 | |
Na Wu | Qumei Furniture Group | 50 | |
Hu Liaoping | Hunan Tyen Machinery | 56 | |
Feng Wen | Nanxing Furniture Machinery | 54 | |
Tao Xu | Nanjing OLO Home | 44 |
Management Performance
Return On Equity | -0.0128 | ||||
Return On Asset | -0.0136 |
Allgens Medical Tech Leadership Team
Elected by the shareholders, the Allgens Medical's board of directors comprises two types of representatives: Allgens Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allgens. The board's role is to monitor Allgens Medical's management team and ensure that shareholders' interests are well served. Allgens Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allgens Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Guofeng Tian, Deputy Director | ||
Ling Wang, Head Finance | ||
Zhiye Qiu, Deputy Secretary | ||
Gang Hu, Chairman GM | ||
Menglong Cui, GM Director | ||
Fuzhai Cui, Founder Scientist | ||
Wanlan Huang, Deputy Director | ||
Tianxi Song, Director Manager |
Allgens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allgens Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0128 | ||||
Return On Asset | -0.0136 | ||||
Profit Margin | (0.09) % | ||||
Operating Margin | (0.08) % | ||||
Current Valuation | 1.22 B | ||||
Shares Outstanding | 135.55 M | ||||
Shares Owned By Insiders | 41.24 % | ||||
Shares Owned By Institutions | 2.38 % | ||||
Price To Book | 1.57 X | ||||
Price To Sales | 10.84 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.